About Cytogen
Cytogen was established in 1980 in Princeton, United States, within the biotechnology sector. Research and development activities are conducted to advance innovative solutions. Production processes are managed for various biotechnological products, while marketing efforts are directed toward global distribution. Operations encompass the full lifecycle from innovation to commercialization, with a focus on scientific advancements in the field.
- Headquarter Princeton, United States
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
EUSA Pharma
(May 09, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cytogen
Detailed funding history for Cytogen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cytogen
Cytogen has secured backing from 1 investor. Prominent investors backing the company include EUSA Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer and commercializer of pharmaceutical medicines
|
Locked | Locked | Locked |
Investor details for Cytogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytogen
Investment portfolio details for Cytogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytogen
Detailed financials for Cytogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytogen Comparisons
Peer comparison for Cytogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytogen
Detailed competitors of Cytogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytogen
Complete news archive for Cytogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytogen
Cytogen was founded in 1980.
Cytogen is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Cytogen was established in 1980 in Princeton, United States, within the biotechnology sector. Research and development activities are conducted to advance innovative solutions. Production processes are managed for various biotechnological products, while marketing efforts are directed toward global distribution. Operations encompass the full lifecycle from innovation to commercialization, with a focus on scientific advancements in the field.
Cytogen has 1 investor. Key investors include EUSA Pharma.